Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0030193 (pain)
 261,466 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Fentanyl citrate is administered intramuscularly at increasing doses to patients suffering from an intense pain in the facial or trigeminal nerves territory. Fentanyl induces a very intense analgesia which develops during the hour following the administration. The intensity and the duration of the effect are dose related. Compared to that of morphine chlorhydrate, in the same conditions, the analgesia induced by fentanyl citrate is much less intense than expected: fentanyl seems to be only 25 times more potent than morphine. Furthermore, the observed duration of action of fentanyl makes it impossible to be still classified with the short time acting analgesics: with equianalgesic doses, morphine and fentanyl have the same time of initiation and the same duration of action. As observed, the time of the clinically useful analgesia is longer than 3 hours after injection of 0.006 mg/kg of fentanyl or of 0.150 mg/kg of morphine.
 ...
PMID:[Comparison between the analgesic effects of fentanyl and morphine in conscious man (author's transl)]. 745 45

Fentanyl citrate or morphine chlorhydrate are injected intramuscularly at increasing doses to patients suffering from intense pain in the facial or trigeminal nerves territory: --fentanyl = 0.0015, 0.003, 0.006 mg/kg; --morphine = 0.100, 0.150, 0.200 mg/kg. The clinically observed side-effects are noted at regular time during the three hours following the injection. Fentanyl induces a drop in ventilation similar in duration to that of morphine, but it is more intense. Fentanyl induces less vomiting, but more euphoria than morphine and the sedation is the same in frequency and intensity with both drugs. The only difference of clinical importance concerns the cardio-vascular effects: morphine induces a constant, dose-related hypotension as that of fentanyl, at equianalgesic doses, is negligible.
 ...
PMID:[Comparison between the side-effects of fentanyl and morphine in conscious man (author's transl)]. 745 46

Cancer patients suffer multiple symptoms and require numerous drug therapies. Parenteral administration of multiple medications from a single container can simplify drug regimens for patient self-administration. This simplification reduces drug preparation costs and risk of infection. Therapeutic options are limited by the lack of published information on the compatibility of opioids and adjuvant drugs. We report the results of a study evaluating the physical compatibility of injectable opioids with selected drugs for pain and symptom management. Fentanyl citrate, hydromorphone hydrochloride, methadone hydrochloride, and morphine sulfate solutions were physically compatible with 14 of 15 supportive care drugs tested through visual examination using a high intensity light beam and through measured examination using a turbidimeter over a range of times up to 48 hr. Phenytoin sodium was the only drug found to be incompatible with all opioid solutions tested. This compatibility information will assist clinicians in selecting the most efficient, safe, and cost-effective supportive care drug regimen.
J Pain Symptom Manage 1996 Sep
PMID:Combined administration of opioids with selected drugs to manage pain and other cancer symptoms: initial safety screening for compatibility. 880 80

On September 13, 2007, the United States Food and Drug Administration posted a safety alert for fentanyl buccal tablets (Fentora). The announcement and hyperlinks to the Dear Doctor and Dear Healthcare Professional Letters that were distributed by the sponsor are presented.
J Pain Palliat Care Pharmacother 2008
PMID:Safety alert for fentanyl buccal tablets. 1906 55

On September 13, 2007, the United States Food and Drug Administration posted a safety alert for fentanyl buccal tablets (Fentora). The announcement and hyperlinks to the Dear Doctor and Dear Healthcare Professional Letters that were distributed by the sponsor are presented.
J Pain Palliat Care Pharmacother 2008
PMID:Safety Alert for Fentanyl Buccal Tablets. 2879 14

Akathisia is a condition wherein sitting calmly and quietly is impossible, with a representative complaint of restless legs. It is generally assumed to be caused by anti-dopamine activity. In severe cases, it has been known to result in suicide attempt. We reported a case of drug-induced akathisia with difficulty in oral intake, in which fentanyl citrate sublingual tablets were found to be effective in relieving symptoms. The patient was a female aged 50's who had a gastric cancer with peritoneal dissemination causing pain and vomiting. Palliative care was requested for management of symptoms. Metoclopramide and haloperidol were administered for vomiting. However, because of the complaints of restless legs, the case was diagnosed as drug-induced akathisia. Fentanyl citrate sublingual tablets were then administered for pain management, resulting in temporary improvement of akathisia symptoms.
 ...
PMID:[Fentanyl Citrate Sublingual Tablets Were Effective in Relieving Symptoms of Akathisia - A Case Report]. 2965 Aug 85